+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Gene Synthesis Market Research Report by Method, Gene Type, Service, Application, End-use, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 229 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5715509
UP TO OFF until Mar 31st 2023
The Global Gene Synthesis Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Gene Synthesis Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Gene Synthesis Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Gene Synthesis Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Gene Synthesis Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Gene Synthesis Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Gene Synthesis Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Method, the market is studied across Chip-Based Synthesis, PCR-Based Enzyme Synthesis, and Solid-Phase Synthesis.
  • Based on Gene Type, the market is studied across Complex Gene, Express Gene, and Standard Gene.
  • Based on Service, the market is studied across Antibody DNA Synthesis and Viral DNA Synthesis.
  • Based on Application, the market is studied across Disease Diagnosis, Gene & Cell Therapy Development, and Vaccine Development.
  • Based on End-use, the market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Gene Synthesis Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Gene Synthesis Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Gene Synthesis Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Gene Synthesis Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Gene Synthesis Market, including Ansa Biotechnologies, Inc., Azenta US, Inc., Bioneer Pacific, Biotage AB, Boster Biological Technology, Creative Biogene, Danaher Corporation, Eurofins Scientific (Ireland) Limited, General Biosystems, Inc., GenScript Biotech Corporation, Macrogen, Inc., OriGene Technologies, Inc., Synbio Technologies, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Gene Synthesis Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Gene Synthesis Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Gene Synthesis Market?
4. What is the competitive strategic window for opportunities in the Global Gene Synthesis Market?
5. What are the technology trends and regulatory frameworks in the Global Gene Synthesis Market?
6. What is the market share of the leading vendors in the Global Gene Synthesis Market?
7. What modes and strategic moves are considered suitable for entering the Global Gene Synthesis Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of cancer and other chronic conditions among the global population
5.1.1.2. Advantageous nature of gene synthesis over traditional methods
5.1.1.3. Increasing research and studies in vaccine production
5.1.2. Restraints
5.1.2.1. Shortage of skilled researchers and professionals
5.1.3. Opportunities
5.1.3.1. Emerging new technologies in gene synthesis
5.1.3.2. Utilization of gene synthesis in energy and agriculture industries
5.1.4. Challenges
5.1.4.1. Concerns related to errors and the high cost of gene synthesis
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Gene Synthesis Market, by Method
6.1. Introduction
6.2. Chip-Based Synthesis
6.3. PCR-Based Enzyme Synthesis
6.4. Solid-Phase Synthesis

7. Gene Synthesis Market, by Gene Type
7.1. Introduction
7.2. Complex Gene
7.3. Express Gene
7.4. Standard Gene

8. Gene Synthesis Market, by Service
8.1. Introduction
8.2. Antibody DNA Synthesis
8.3. Viral DNA Synthesis

9. Gene Synthesis Market, by Application
9.1. Introduction
9.2. Disease Diagnosis
9.3. Gene & Cell Therapy Development
9.4. Vaccine Development

10. Gene Synthesis Market, by End-use
10.1. Introduction
10.2. Academic & Government Research Institutes
10.3. Biotechnology & Pharmaceutical Companies
10.4. Contract Research Organizations

11. Americas Gene Synthesis Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Gene Synthesis Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Gene Synthesis Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Product Portfolio Analysis, By Key Player
14.5. Competitive Scenario
14.5.1. Merger & Acquisition
14.5.2. Agreement, Collaboration, & Partnership
14.5.3. New Product Launch & Enhancement
14.5.4. Investment & Funding
14.5.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. Ansa Biotechnologies, Inc.
15.2. Azenta US, Inc.
15.3. Bioneer Pacific
15.4. Biotage AB
15.5. Boster Biological Technology
15.6. Creative Biogene
15.7. Danaher Corporation
15.8. Eurofins Scientific (Ireland) Limited
15.9. General Biosystems, Inc.
15.10. GenScript Biotech Corporation
15.11. Macrogen, Inc.
15.12. OriGene Technologies, Inc.
15.13. Synbio Technologies
15.14. Thermo Fisher Scientific Inc.
15.15. Twist Bioscience Corporation

16. Appendix
16.1. Discussion Guide
16.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL GENE SYNTHESIS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL GENE SYNTHESIS MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL GENE SYNTHESIS MARKET DYNAMICS
FIGURE 11. GLOBAL GENE SYNTHESIS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
FIGURE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY METHOD, 2030
FIGURE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2022 VS 2030 (%)
FIGURE 19. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY GENE TYPE, 2030
FIGURE 21. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2022 VS 2030 (%)
FIGURE 25. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 26. GLOBAL GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY SERVICE, 2030
FIGURE 27. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 30. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 31. GLOBAL GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 32. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
FIGURE 33. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, 2018-2030 (USD MILLION)
FIGURE 35. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 36. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 37. GLOBAL GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USE, 2030
FIGURE 38. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
FIGURE 39. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
FIGURE 40. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
FIGURE 41. AMERICAS GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 43. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 44. AMERICAS GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 45. ARGENTINA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. BRAZIL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. CANADA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. MEXICO GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. UNITED STATES GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 51. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 52. UNITED STATES GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 53. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 55. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 56. ASIA-PACIFIC GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 57. AUSTRALIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. CHINA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. INDIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. INDONESIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. JAPAN GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. MALAYSIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. PHILIPPINES GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. SINGAPORE GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. TAIWAN GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. THAILAND GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. VIETNAM GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 72. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 73. DENMARK GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. EGYPT GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. FINLAND GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. FRANCE GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. GERMANY GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. ISRAEL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. ITALY GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. NETHERLANDS GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. NIGERIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. NORWAY GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. POLAND GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. QATAR GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. RUSSIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 86. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 87. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. SPAIN GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 89. SWEDEN GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 90. SWITZERLAND GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 91. TURKEY GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 92. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 93. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 94. GLOBAL GENE SYNTHESIS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 95. GLOBAL GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 96. GLOBAL GENE SYNTHESIS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL GENE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. CANADA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 73. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 74. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 76. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. MEXICO GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 80. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 81. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 104. CHINA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 105. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 106. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 107. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 108. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 110. INDIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 111. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 112. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 113. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 114. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 122. JAPAN GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 123. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 124. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 125. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 126. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 158. THAILAND GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 159. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 160. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 161. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 162. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 177. DENMARK GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 178. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 179. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 180. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 181. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 183. EGYPT GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 184. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 185. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 186. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 187. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 189. FINLAND GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 190. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 191. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 193. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 195. FRANCE GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 196. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 197. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 198. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 199. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 201. GERMANY GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 202. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 203. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 204. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 205. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 213. ITALY GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 214. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 215. ITALY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 216. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 217. ITALY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. ITALY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 225. NIGERIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 226. NIGERIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 227. NIGERIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 228. NIGERIA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 229. NIGERIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 231. NORWAY GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 232. NORWAY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 233. NORWAY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 234. NORWAY GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 235. NORWAY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. NORWAY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 237. POLAND GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 238. POLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 239. POLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 240. POLAND GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 241. POLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. POLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 243. QATAR GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 244. QATAR GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 245. QATAR GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 246. QATAR GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 247. QATAR GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. QATAR GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 256. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 267. SPAIN GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 268. SPAIN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 269. SPAIN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 270. SPAIN GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 271. SPAIN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. SPAIN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 279. SWITZERLAND GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 280. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 281. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 282. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 283. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 285. TURKEY GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 286. TURKEY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 287. TURKEY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 288. TURKEY GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 289. TURKEY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. TURKEY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 298. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 300. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 302. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 303. GLOBAL GENE SYNTHESIS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 304. GLOBAL GENE SYNTHESIS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 305. GLOBAL GENE SYNTHESIS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 306. GLOBAL GENE SYNTHESIS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 307. GLOBAL GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 308. GLOBAL GENE SYNTHESIS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 309. GLOBAL GENE SYNTHESIS MARKET MERGER & ACQUISITION
TABLE 310. GLOBAL GENE SYNTHESIS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 311. GLOBAL GENE SYNTHESIS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 312. GLOBAL GENE SYNTHESIS MARKET INVESTMENT & FUNDING
TABLE 313. GLOBAL GENE SYNTHESIS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 314. GLOBAL GENE SYNTHESIS MARKET: LICENSE & PRICING

Companies Mentioned

  • Ansa Biotechnologies, Inc.
  • Azenta US, Inc.
  • Bioneer Pacific
  • Biotage AB
  • Boster Biological Technology
  • Creative Biogene
  • Danaher Corporation
  • Eurofins Scientific (Ireland) Limited
  • General Biosystems, Inc.
  • GenScript Biotech Corporation
  • Macrogen, Inc.
  • OriGene Technologies, Inc.
  • Synbio Technologies
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Methodology

Loading
LOADING...